Zurich Cantonal Bank’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

Zurich Cantonal Bank’s Portfolio PNT Stock Details PNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-11,114	Closed	-$74.1K	–	2800
2023 Q3	$74.1K	Hold	11,114	–	–	﹤0.01%	2488
2023 Q2	$101K	Hold	11,114	–	–	﹤0.01%	2349
2023 Q1	$80.8K	Hold	11,114	–	–	﹤0.01%	2402
2022 Q4	$81K	Buy	11,114 +2,633	+31%	+$19.5K	﹤0.01%	2401
2022 Q3	$66K	Buy	+8,481	New	+$72K	﹤0.01%	2488

Other funds holding PNT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Zurich Cantonal Bank's PNT Position: Q4 2023 in Review

Zurich Cantonal Bank sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q4 2023, closing a stake of 11,114 shares — an estimated $74.1K sold.

Zurich Cantonal Bank first reported a position in PNT in Q3 2022 and held it in 5 quarters. The position peaked at $101K in Q2 2023. 1 fund tracked by Wall St. Rank holds PNT as of Q4 2023.

Zurich Cantonal Bank reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Zurich Cantonal Bank sold 11,114 POINT Biopharma Global Inc. Common Stock shares in Q4 2023, an estimated $74.1K.
Zurich Cantonal Bank first reported a position in POINT Biopharma Global Inc. Common Stock in Q3 2022 and held it in 5 quarters.
Zurich Cantonal Bank's POINT Biopharma Global Inc. Common Stock position peaked at $101K in Q2 2023.
1 fund tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q4 2023.

Based on Zurich Cantonal Bank's 13F filing for Q4 2023, filed 30 Jan 2024.